Pulliam, Thomas L
172  results:
Search for persons X
?
3

Supplementary File 1 from Adipose Triglyceride Lipase Is a ..:

Dominik Awad ; Pham Hong Anh Cao ; Thomas L. Pulliam...
https://figshare.com/articles/dataset/Supplementary_File_1_from_Adipose_Triglyceride_Lipase_Is_a_Therapeutic_Target_in_Advanced_Prostate_Cancer_That_Promotes_Metabolic_Plasticity/25338486.  , 2024
 
?
5

Supplementary Figure S5 from Characterization of Immunosupp..:

Shira Tabachnick-Cherny ; Thomas Pulliam ; Haroldo J. Rodriguez...
https://figshare.com/articles/journal_contribution/Supplementary_Figure_S5_from_Characterization_of_Immunosuppressive_Myeloid_Cells_in_Merkel_Cell_Carcinoma_Correlation_with_Resistance_to_PD-1_Pathway_Blockade/25415603.  , 2024
 
?
6

Supplementary Figure S2 from Characterization of Immunosupp..:

Shira Tabachnick-Cherny ; Thomas Pulliam ; Haroldo J. Rodriguez...
https://figshare.com/articles/journal_contribution/Supplementary_Figure_S2_from_Characterization_of_Immunosuppressive_Myeloid_Cells_in_Merkel_Cell_Carcinoma_Correlation_with_Resistance_to_PD-1_Pathway_Blockade/25415612.  , 2024
 
?
7

Best practices for estimating and reporting epidemiological..:

Charniga, Kelly ; Park, Sang, Woo ; Akhmetzhanov, Andrei, R...
info:eu-repo/grantAgreement//MR/X020258/1/EU/UK Medical Research Council/MRC.  , 2024
 
?
8

Supplementary Figure S8 from Characterization of Immunosupp..:

Shira Tabachnick-Cherny ; Thomas Pulliam ; Haroldo J. Rodriguez...
https://figshare.com/articles/journal_contribution/Supplementary_Figure_S8_from_Characterization_of_Immunosuppressive_Myeloid_Cells_in_Merkel_Cell_Carcinoma_Correlation_with_Resistance_to_PD-1_Pathway_Blockade/25415594.  , 2024
 
?
9

Supplementary Table S4 from Characterization of Immunosuppr..:

Shira Tabachnick-Cherny ; Thomas Pulliam ; Haroldo J. Rodriguez...
https://figshare.com/articles/dataset/Supplementary_Table_S4_from_Characterization_of_Immunosuppressive_Myeloid_Cells_in_Merkel_Cell_Carcinoma_Correlation_with_Resistance_to_PD-1_Pathway_Blockade/25415579.  , 2024
 
?
11

Supplementary Table S1 from Characterization of Immunosuppr..:

Shira Tabachnick-Cherny ; Thomas Pulliam ; Haroldo J. Rodriguez...
https://figshare.com/articles/dataset/Supplementary_Table_S1_from_Characterization_of_Immunosuppressive_Myeloid_Cells_in_Merkel_Cell_Carcinoma_Correlation_with_Resistance_to_PD-1_Pathway_Blockade/25415588.  , 2024
 
?
12

Supplementary Table S3 from Characterization of Immunosuppr..:

Shira Tabachnick-Cherny ; Thomas Pulliam ; Haroldo J. Rodriguez...
https://figshare.com/articles/dataset/Supplementary_Table_S3_from_Characterization_of_Immunosuppressive_Myeloid_Cells_in_Merkel_Cell_Carcinoma_Correlation_with_Resistance_to_PD-1_Pathway_Blockade/25415582.  , 2024
 
?
13

Supplementary Figure S7 from Characterization of Immunosupp..:

Shira Tabachnick-Cherny ; Thomas Pulliam ; Haroldo J. Rodriguez...
https://figshare.com/articles/journal_contribution/Supplementary_Figure_S7_from_Characterization_of_Immunosuppressive_Myeloid_Cells_in_Merkel_Cell_Carcinoma_Correlation_with_Resistance_to_PD-1_Pathway_Blockade/25415597.  , 2024
 
?
14

Supplementary Figure S1 from Characterization of Immunosupp..:

Shira Tabachnick-Cherny ; Thomas Pulliam ; Haroldo J. Rodriguez...
https://figshare.com/articles/journal_contribution/Supplementary_Figure_S1_from_Characterization_of_Immunosuppressive_Myeloid_Cells_in_Merkel_Cell_Carcinoma_Correlation_with_Resistance_to_PD-1_Pathway_Blockade/25415615.  , 2024
 
?
15

Supplementary Figure S4 from Characterization of Immunosupp..:

Shira Tabachnick-Cherny ; Thomas Pulliam ; Haroldo J. Rodriguez...
https://figshare.com/articles/journal_contribution/Supplementary_Figure_S4_from_Characterization_of_Immunosuppressive_Myeloid_Cells_in_Merkel_Cell_Carcinoma_Correlation_with_Resistance_to_PD-1_Pathway_Blockade/25415606.  , 2024
 
1-15